Schonfeld Strategic Advisors LLC Eledon Pharmaceuticals, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 1,515,750 shares of ELDN stock, worth $6.29 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,515,750
Previous 1,500,000
1.05%
Holding current value
$6.29 Million
Previous $3.74 Million
65.97%
% of portfolio
0.04%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding ELDN
# of Institutions
77Shares Held
37.2MCall Options Held
17KPut Options Held
2.7K-
Bvf Inc San Francisco, CA6.29MShares$26.1 Million0.96% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$14.8 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$12 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.55MShares$10.6 Million2.15% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$9.66 Million0.93% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $57.1M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...